Skip to main content
SpringerLink
Log in

Krebszellen lieben Zucker, Patientinnen brauchen Fett

Rationale, Möglichkeiten und Einschränkungen der ketogenen Diät in der gynäkologischen Onkologie

Cancer cells adore sugar, patients need fat

Rationale, feasibilities and limitations of a ketogenic diet in gynecological oncology

  • Leitthema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Wenige Ernährungsmodifikationen werden derzeit so kontrovers diskutiert wie die ketogene Diät (KD). Hier erörtern wir die wissenschaftlichen Hintergründe dafür, dass sich für klinisch tätige Gynäkologen eine intensive Auseinandersetzung mit dieser supportiven (Ernährungs‑)Therapie lohnt, und erläutern die korrekte Durchführung der KD, um Nebenwirkungen zu vermeiden.

Abstract

Currently, few diet modifications are discussed as controversially as the ketogenic diet (KD). This article comments on the scientific background and why it is worthwhile for clinical gynecologists to intensively examine this supportive dietetic treatment. Furthermore, it also explains how to correctly implement a KD to avoid side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Barber MD, McMillan DC, Preston T et al (2000) Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (lond) 98:389–399

    Article  CAS  Google Scholar 

  2. Calderón N, Betancourt L, Hernández L et al (2017) A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: a microdialysis study. Neurosci Lett 642:158–162

    Article  Google Scholar 

  3. Chandrasekera PC, Pippin JJ (2013) Of rodents and men: species-specific glucose regulation and type 2 diabetes research. ALTEX 31:157–176

    Article  Google Scholar 

  4. Cori F, Cori G (1925) The carbohydrate metabolism of tumors. J Biol Chem 65:397–405

    CAS  Google Scholar 

  5. de Groot S, Vreeswijk MP, al Welters MJet (2015) The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 15:652

    Article  Google Scholar 

  6. Di Sebastiano KM, Pinthus JH, Duivenvoorden WCM et al (2018) Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise. Obes Rev 19:1008–1016

    Article  Google Scholar 

  7. Dolan RD, McLees NG, Irfan A (2018) The relationship between tumour glucose metabolism and host systemic inflammatory responses in patients with cancer: a systematic review. J Nucl Med 18:216697

    Google Scholar 

  8. Dorff TB, Groshen S, Garcia A et al (2016) Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 16:360

    Article  Google Scholar 

  9. Ferroni P, Riondino S, Laudisi A et al (2016) Pretreatment insulin levels as a prognostic factor for breast cancer progression. Oncologist 21:1041–1049

    Article  CAS  Google Scholar 

  10. Fine EJ, Segal-isaacson CJ, Feinman RD et al (2012) Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 28:1028–1035

    Article  CAS  Google Scholar 

  11. Gong Y, Ma Y, Ye Z et al (2017) Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression. Metabolism 76:32–41

    Article  CAS  Google Scholar 

  12. Greco T, Glenn TC, Hovda DA et al (2016) Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J Cereb Blood Flow Metab 36:1603–1613

    Article  CAS  Google Scholar 

  13. Hansell DT, Davies JW, Shenkin A et al (1986) The oxidation of body fuel stores in cancer patients. Ann Surg 204:637–642

    Article  CAS  Google Scholar 

  14. Holm E, Hagmüller E, Staedt U et al (1995) Substrate balances across colonic carcinomas in humans. Cancer Res 55:1373–1378

    CAS  PubMed  Google Scholar 

  15. Kern L, Mittenbühler MJ, Vesting AJ et al (2018) Obesity-induced TNFα and IL-6 signaling: the missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers (Basel) 11:E24

    Article  Google Scholar 

  16. Klement RJ, Champ CE (2014) Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation. Cancer Metastasis Rev 33:217–229

    Article  CAS  Google Scholar 

  17. Klement RJ, Champ CE, Otto C et al (2016) Anti-tumor effects of Ketogenic diets in mice: a meta-analysis. PLoS ONE 11:e155050

    Article  Google Scholar 

  18. Kose E, Guzel O, Demir K et al (2017) Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy. J Pediatr Endocrinol Metab 30:411–416

    Article  CAS  Google Scholar 

  19. Koutnik AP, D’Agostino DP, Egan B (2019) Anticatabolic effects of ketone bodies in skeletal muscle. Trends Endocrinol Metab 30(4):227–229

    Article  CAS  Google Scholar 

  20. Lundholm K, Holm G, Scherstén T (1978) Insulin resistance in patients with cancer. Cancer Res 38:4665–4670

    CAS  PubMed  Google Scholar 

  21. Mansoor N, Vinknes KJ, Veierød MB et al (2016) Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr 115:466–479

    Article  CAS  Google Scholar 

  22. Puchalska P, Crawford PA (2017) Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab 25:262–284

    Article  CAS  Google Scholar 

  23. Rahman M, Muhammad S, Khan MA et al (2014) The β‑hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5:3944

    Article  CAS  Google Scholar 

  24. Schmidt M, Pfetzer N, Schwab M et al (2011) Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (lond) 8:54

    Article  CAS  Google Scholar 

  25. Schwartz K, Chang HT, Nikolai M et al (2015) Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab 3:3

    Article  Google Scholar 

  26. Shukla SK, Gebregiworgis T, al Purohit Vet (2014) Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab 2:18

    Article  Google Scholar 

  27. Tang L, Wei F, Wu Y et al (2018) Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res 37:87

    Article  Google Scholar 

  28. Tosti KP, Hackney AC, Battaglini CL et al (2011) Exercise in patients with breast cancer and healthy controls: energy substrate oxidation and blood lactate responses. Integr Cancer Ther 10:6–15

    Article  Google Scholar 

  29. Wang Q, Zhou Y, al Rychahou Pet (2017) Ketogenesis contributes to intestinal cell differentiation. Cell Death Differ 24:458–468

    Article  CAS  Google Scholar 

  30. Wang X, Wu X, Liu Q et al (2017) Ketogenic metabolism inhibits Histone Deacetylase (HDAC) and reduces oxidative stress after spinal Cord injury in rats. Neuroscience 366:36–43

    Article  CAS  Google Scholar 

  31. Warburg O (1926) Über den Stoffwechsel der Tumoren. Springer, Berlin

    Google Scholar 

  32. Youm YH, Nguyen KY, Grant RW et al (2015) The ketone metabolite β‑hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21:263–269

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frauenklinik, Universitätsklinikum Würzburg, Würzburg, Deutschland

    Catharina Bartmann & Achim Wöckel

  2. Schwerpunktpraxis am Rehabilitations- und Präventionszentrum, Bad Bocklet, Deutschland

    Monika Reuss-Borst

  3. Frauenklinik/Forschungslabor, Universitätsklinikum Würzburg, Josef-Schneider-Str. 4, 97080, Würzburg, Deutschland

    Ulrike Kämmerer

Authors
  1. Ulrike Kämmerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catharina Bartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Achim Wöckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monika Reuss-Borst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrike Kämmerer.

Ethics declarations

Interessenkonflikt

U. Kämmerer, C. Bartmann, A. Wöckel und M. Reuss-Borst geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

M. Kiechle, München

K. Friese, Oberaudorf

R. Felberbaum, Kempten

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kämmerer, U., Bartmann, C., Wöckel, A. et al. Krebszellen lieben Zucker, Patientinnen brauchen Fett. Gynäkologe 52, 519–524 (2019). https://doi.org/10.1007/s00129-019-4459-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-019-4459-x

Schlüsselwörter

Keywords

Search

Navigation